PDF(Pubmed)
Abstract：
Electronic hospital pharmacy (EHP) systems are ubiquitous in today\'s hospitals, with many also implementing electronic prescribing (EP) systems; both contain a potential wealth of medication-related data to support quality improvement. The reasons for reuse and users of this data are generally unknown. Our objectives were to survey secondary use of data (SUD) from EHP and EP systems in UK hospitals, to identify users of and factors influencing SUD.A national postal survey was sent out to all hospital chief pharmacists with pre-notifications and follow-up reminders. Descriptive statistical analysis was performed.Of 187 hospital organisations, 65 (35%) responded. All had EHP systems (for ≥20 years) and all reused data; 50 (77%) had EP systems (established 1-10 years) but only 40 (80%) reused data. Reported facilitators for SUD included medication safety, providing feedback, benchmarking, saving time and patient experience. The purposes of SUD included audits, quality improvement, risk management and general medication-related reporting. Earlier introduction of SUD could provide an opportunity to heighten local improvement initiatives.Data from EHP systems is reused for multiple purposes. Evaluating SUD and sharing experiences could provide richer insight into potential SUD and barriers/factors to consider when implementing or upgrading EP/EHP systems.
摘要：
电子医院药房(EHP)系统在当今的医院中无处不在，许多还实施了电子处方（EP）系统；两者都包含潜在的大量药物相关数据，以支持质量改进。重用这些数据的原因和用户通常是未知的。我们的目标是调查英国医院EHP和EP系统的二次使用数据(SUD)，确定SUD的用户和影响因素。向所有医院首席药剂师发送了国家邮政调查，并提供了预先通知和后续提醒。进行描述性统计分析。在187个医院组织中，65（35%）回答。所有都有EHP系统（≥20年）和所有重复使用的数据；50（77％）有EP系统（建立1-10年），但只有40（80％）重复使用的数据。SUD的报告促进者包括药物安全，提供反馈,基准测试,节省时间和病人的经验。SUD的目的包括审计，质量改进,风险管理和一般药物相关报告。较早引入SUD可以提供一个机会来加强当地的改善举措。来自EHP系统的数据可用于多种用途。评估SUD和分享经验可以更深入地了解潜在的SUD和实施或升级EP/EHP系统时要考虑的障碍/因素。
